Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ascentage Pharma Group International (AAPG) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ascentage Pharma Group International. Table 2 shows the detailed insider transactions. This company's CIK number is 2023311.
Total stock buying since 2026: $0.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 0 | $0 | 376,642 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-05 | 0 | $0 | 0 | $0 | 376,642 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-21 | Zhai Yifan (Chief Medical Officer) | Option Ex | 188,321 | .00 | 0 |
| 2026-05-21 | Yang Dajun (Chairman and CEO) | Option Ex | 188,321 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of AAPG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ascentage Pharma Group International (symbol AAPG, CIK number 2023311) see the Securities and Exchange Commission (SEC) website.